|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 318.91 USD | +1.75% |
|
-1.45% | -19.80% |
| 06/03 | Tenaya Therapeutics and Alnylam Pharmaceuticals Enter Research Collaboration Agreement | CI |
| 05/03 | Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.75% | -1.45% | +1.43% | -18.47% | -19.80% | +31.91% | +68.15% | +121.80% | +428.08% | 4.16TCr | |
| +0.41% | -1.91% | -4.89% | -6.18% | -7.96% | +21.59% | +200.16% | +418.14% | +1,264.68% | 88TCr | |
| +0.69% | +0.25% | -0.11% | +16.19% | +17.51% | +49.37% | +57.88% | +50.70% | +126.41% | 58TCr | |
| +0.81% | -2.64% | -4.34% | -0.99% | -3.08% | +4.57% | +42.59% | +99.79% | +293.27% | 39TCr | |
| +0.50% | -3.04% | -10.82% | +0.59% | -1.80% | +5.40% | +23.34% | +3.20% | +31.55% | 32TCr | |
| -0.11% | -0.54% | -5.25% | +6.35% | +4.16% | +19.76% | +33.02% | +98.62% | +258.65% | 30TCr | |
| +0.07% | -3.08% | -3.97% | +12.99% | +10.80% | +26.04% | +57.73% | +52.60% | +68.90% | 29TCr | |
| +0.58% | -1.43% | -4.93% | +17.46% | +9.66% | +22.06% | +7.54% | +50.28% | +122.24% | 29TCr | |
| +0.01% | -2.84% | -0.80% | +12.09% | +11.90% | +16.75% | +56.14% | +52.40% | +154.38% | 20TCr | |
| +0.15% | -0.97% | -6.30% | +22.25% | +18.31% | +30.30% | +81.85% | +126.86% | +60.84% | 18TCr | |
| +0.51% | -2.44% | -19.29% | -19.73% | -23.66% | -53.17% | -48.97% | +9.59% | +32.14% | 17TCr | |
| +0.11% | -0.75% | -3.52% | +4.23% | +6.87% | +3.46% | -34.08% | -25.73% | -8.37% | 15TCr | |
| +1.07% | -1.52% | -1.70% | +10.11% | +10.70% | +1.19% | -11.01% | -3.54% | -4.68% | 12TCr | |
| -0.69% | +1.13% | -5.16% | +2.45% | +2.81% | -7.66% | +55.04% | +112.84% | +487.77% | 12TCr | |
| -0.25% | -0.98% | -7.23% | +11.35% | +11.04% | +34.08% | +46.07% | +25.55% | +14.79% | 11TCr | |
| +0.16% | +0.92% | -1.11% | -5.47% | -7.51% | -27.97% | -15.21% | -7.52% | +4.78% | 11TCr | |
| +2.93% | -1.28% | +0.83% | +13.18% | +13.54% | +36.39% | +180.88% | +106.15% | +723.37% | 9.65TCr | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 6.37TCr | |
| +1.71% | +3.58% | +5.11% | +28.77% | +20.33% | +30.01% | +35.90% | +40.19% | +7.78% | 5.61TCr | |
| +0.87% | +0.05% | -4.53% | -9.43% | -6.68% | +19.45% | +34.34% | -25.54% | +275.10% | 5.3TCr | |
| Average | +0.51% | -0.99% | -4.03% | +5.14% | +3.53% | +13.87% | +45.86% | +68.76% | +228.51% | 22.54TCr | |
| Weighted average by Cap. | +0.35% | -1.17% | -4.56% | +4.94% | +3.27% | +17.74% | +69.27% | +125.59% | +371.18% |
- Stock Market
- Equities
- ALNY Stock
- Sector Alnylam Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition